BIONET Corp. (TPEX:1784)

Taiwan · Delayed Price · Currency is TWD

68.00

-3.00 (-4.23%)

Jun 25, 2026, 1:30 PM CST

-4.09% (1Y)

Market Cap	3.42B -3.2%
Revenue (ttm)	1.26B +3.6%
Net Income	48.78M -36.3%
EPS	0.97 -35.8%
Shares Out	50.31M
PE Ratio	70.19
Forward PE	n/a
Dividend	0.87 (1.23%)
Ex-Dividend Date	Oct 1, 2026

Volume	385,615
Open	71.50
Previous Close	71.00
Day's Range	68.00 - 72.20
52-Week Range	63.40 - 118.00
Beta	0.47
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 11, 2026

About BIONET

BIONET Corp. engages in cell therapy, regenerative medicine, medical big data, gene testing, and sales of biological and scientific information hardware and software business in Taiwan and internationally. The company offers stem cell banking services, such as stem cell storage, mesenchymal stem cell storage, dental stem cell storage, adipose stem cell, and PBSC and immune cells, as well as skin care products. It also provides storage and application of hematopoietic stem cells, analytical testing, clinical and preclinical research, commerciali... [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 1989

Country Taiwan

Stock Exchange Taipei Exchange

Ticker Symbol 1784

Full Company Profile

Financial Performance

In 2025, BIONET's revenue was 1.24 billion, an increase of 1.19% compared to the previous year's 1.22 billion. Earnings were 51.43 million, a decrease of -38.56%.

Financial Statements